Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF–FVIIa inhibitors
Journal Article
·
· Bioorganic & Medicinal Chemistry Letters
Bicyclic pyrazinone and pyrimidinone amides were designed and synthesized as potent TF–FVIIa inhibitors. SAR demonstrated that the S2 and S3 pockets of FVIIa prefer to bind small, lipophilic groups. An X-ray crystal structure of optimized compound 9b bound in the active site of FVIIa showed that the bicyclic scaffold provides 5 hydrogen bonding interactions in addition to projecting groups for interactions within the S1, S2 and S3 pockets. Compound 9b showed excellent FVIIa potency, good selectivity against FIXa, Xa, XIa and chymotrypsin, and good clotting activity.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1353261
- Journal Information:
- Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 6; ISSN 0960-894X
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Thrombostatin FM compounds: direct thrombin inhibitors - mechanism of action in vitro and in vivo
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors
Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors
Journal Article
·
Tue Apr 29 00:00:00 EDT 2008
· J. Thromb. Haemost.
·
OSTI ID:1353261
+11 more
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors
Journal Article
·
Mon Jan 28 00:00:00 EST 2019
· Journal of Medicinal Chemistry
·
OSTI ID:1353261
+27 more
Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors
Journal Article
·
Sat Oct 01 00:00:00 EDT 2016
· Bioorganic & Medicinal Chemistry Letters
·
OSTI ID:1353261
+11 more